SWM
TMO icon

Spire Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Spire Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$484K Sell
966
-356
-27% -$171K 0.01% 557
2026
Q1 		$650K Sell
1,322
-155
-10% -$84.1K 0.02% 478
2025
Q4 		$856K Buy
1,477
+120
+9% +$67.9K 0.03% 427
2025
Q3 		$658K Sell
1,357
-275
-17% -$128K 0.02% 467
2025
Q2 		$662K Sell
1,632
-297
-15% -$124K 0.02% 452
2025
Q1 		$960K Buy
1,929
+379
+24% +$205K 0.03% 409
2024
Q4 		$806K Buy
1,550
+65
+4% +$35.7K 0.03% 439
2024
Q3 		$919K Buy
1,485
+1
+0.1% +$592 0.03% 389
2024
Q2 		$820K Sell
1,484
-285
-16% -$163K 0.03% 383
2024
Q1 		$1.03M Buy
1,769
+98
+6% +$55K 0.02% 369
2023
Q4 		$922K Sell
1,671
-343
-17% -$166K 0.03% 382
2023
Q3 		$1.02M Sell
2,014
-660
-25% -$352K 0.04% 320
2023
Q2 		$1.4M Sell
2,674
-154
-5% -$83.1K 0.05% 282
2023
Q1 		$1.63M Buy
2,828
+648
+30% +$365K 0.06% 253
2022
Q4 		$1.2M Sell
2,180
-64
-3% -$33.9K 0.07% 213
2022
Q3 		$1.14M Sell
2,244
-751
-25% -$420K 0.07% 195
2022
Q2 		$1.63M Sell
2,995
-1,250
-29% -$688K 0.07% 237
2022
Q1 		$2.51M Sell
4,245
-86
-2% -$49.4K 0.07% 238
2021
Q4 		$2.89M Buy
4,331
+30
+0.7% +$18.7K 0.06% 255
2021
Q3 		$2.46M Buy
4,301
+18
+0.4% +$9.88K 0.07% 250
2021
Q2 		$2.16M Sell
4,283
-19
-0.4% -$8.96K 0.06% 277
2021
Q1 		$1.96M Buy
+4,302
New +$2.05M 0.05% 286

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Spire Wealth Management's TMO Position: Q2 2026 in Review

Spire Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 27% in Q2 2026, selling an estimated $171K and leaving 966 shares worth $484K. The position accounts for 0.01% of the portfolio, ranked #557.

Spire Wealth Management first reported a position in TMO in Q1 2021 and has held it in 22 quarters since. The position peaked at $2.89M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Spire Wealth Management held 966 shares of Thermo Fisher Scientific worth $484K as of Q2 2026.
  • Spire Wealth Management sold 356 Thermo Fisher Scientific shares in Q2 2026, an estimated $171K.
  • Thermo Fisher Scientific made up 0.01% of Spire Wealth Management's portfolio in Q2 2026, its #557 holding.
  • Spire Wealth Management first reported a position in Thermo Fisher Scientific in Q1 2021 and has held it in 22 quarters since.
  • Spire Wealth Management's Thermo Fisher Scientific position peaked at $2.89M in Q4 2021.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.